Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators aim to compare a single bout of moderately intense cycling exercise incorporating Flutter® breathing maneuvers with a single bout of moderately intense cycling exercise alone on sputum viscoelasticity (primary endpoint) and the diffusion capacity of the lungs in adult patients with cystic fibrosis.
The investigators further aim to analyze the short-term variability of resting diffusion capacity of carbon monoxide (DLCO) and nitric oxide (DLNO) in patients with cystic fibrosis.
Regular airway clearance is an integral component of cystic fibrosis care and of critical importance to lung health. Exercise and standardized chest physiotherapy are accepted airway clearance techniques in cystic fibrosis. Different airway clearance techniques are available, but there is no evidence that one technique or a combination is superior. Oscillatory positive expiratory pressure with the Flutter® is a widely used airway clearance technique in the European countries and has been shown to favourably alter sputum viscoelasticity in cystic fibrosis.
This randomized crossover study is designed to assess the acute effects of combined cycling exercise and Flutter® therapy on sputum viscoelasticity (primary outcome measure) and gas diffusion in adults with cystic fibrosis.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cycling in combination with Flutter® therapy | Experimental | Participants perform 30 minutes of moderately intense cycling exercise in 4-min intervals at 75% of their maximal heart rate and interspersed with 2-min resting periods during which 6-8 breathing maneuvers are performed with the Flutter®. |
|
| Cycling without Flutter® therapy | Active Comparator | Participants perform 30 minutes of continuous moderately intense cycling exercise at 75% of their maximal heart rate without additional Flutter® breathing maneuvers. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Flutter® | Device | Acute exercise with Flutter® breathing therapy. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in sputum viscoelasticity (G*) over a broad frequency range (1-100 rad.s-1) | Sputum viscoelasticity measured by stress/strain controlled rheometer (Anton Paar, MCR 301/MCR 501). | Baseline - immediately post exercise - 45min post exercise |
| Measure | Description | Time Frame |
|---|---|---|
| Change in shear viscosity (η) | Shear viscosity measured by stress/strain controlled rheometer (Anton Paar, MCR 301/MCR 501). | Baseline - immediately post exercise - 45min post exercise |
| Change in sputum spinnability (mm) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Thomas Radtke, PhD | University of Zurich | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Zurich | Zurich | Canton of Zurich | 8001 | Switzerland | ||
| University Hospital Zurich |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29898704 | Derived | Radtke T, Boni L, Bohnacker P, Maggi-Beba M, Fischer P, Kriemler S, Benden C, Dressel H. Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial. BMC Pulm Med. 2018 Jun 14;18(1):99. doi: 10.1186/s12890-018-0661-1. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003550 | Cystic Fibrosis |
| D009043 | Motor Activity |
| D008171 | Lung Diseases |
| ID | Term |
|---|---|
| D010182 | Pancreatic Diseases |
| D004066 | Digestive System Diseases |
| D012140 | Respiratory Tract Diseases |
| D030342 | Genetic Diseases, Inborn |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| No Flutter® | Device | Acute exercise without Flutter® breathing therapy. |
|
Measured with a Capillary Breakup Extensional Rheometer (CaBER).
| Baseline - immediately post exercise - 45min post exercise |
| Change in sputum solids content (%) | Sputum weight of a 50 μL aliquot before and after lyophilization to dryness using a freeze dryer. | Baseline - immediately post exercise - 45min post exercise |
| Change in lung diffusion capacity for nitric oxide (DLNO) | Single-breath measurements with MasterScreenTM PFT system | Baseline - immediately post exercise - 45min post exercise |
| Change in lung diffusion capacity for carbon monoxide (DLCO) | Single-breath measurements with MasterScreenTM PFT system | Baseline - immediately post exercise - 45min post exercise |
| Change in DLNO/DLCO ratio | Single-breath measurements with MasterScreenTM PFT system | Baseline - immediately post exercise - 45min post exercise |
| Change in alveolar volume | Single-breath measurements with MasterScreenTM PFT system | Baseline - immediately post exercise - 45min post exercise |
| Change in pulmonary capillary blood volume | Single-breath measurements with MasterScreenTM PFT system | Baseline - immediately post exercise - 45min post exercise |
| Change in pulmonary membrane diffusion capacity | Single-breath measurements with MasterScreenTM PFT system | Baseline - immediately post exercise - 45min post exercise |
| Change in ease of sputum expectoration (cm) | Assessed by a visual analogue scale (0-10) | Baseline - immediately post exercise - 45min post exercise |
| Change in oxygen saturation (%) | Measured by pulse oximetry. | Baseline - immediately post exercise - 45min post exercise |
| Zurich |
| Canton of Zurich |
| 8091 |
| Switzerland |
| ETH Zurich | Zurich | Canton of Zurich | 8092 | Switzerland |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D007232 | Infant, Newborn, Diseases |
| D001519 | Behavior |